Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-24-000145

Chief Technology Officer sold 13,664 shares at an average $25.26 ($345,134)

  • Chief Technology Officer acquired 13,664 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kurtoglu Metin Chief Technology Officer 2024-12-09 Option exercise +10,763 $1.41 $15,176 61,796 D
Kurtoglu Metin Chief Technology Officer 2024-12-09 Sale −6,224 $25.26 $157,236 55,572 D
Kurtoglu Metin Chief Technology Officer 2024-12-09 Sale −4,539 $25.83 $117,257 51,033 D
Kurtoglu Metin Chief Technology Officer 2024-12-10 Option exercise +2,901 $1.41 $4,090 53,934 D
Kurtoglu Metin Chief Technology Officer 2024-12-10 Sale −2,901 $24.35 $70,640 51,033 D
Derivatives
Kurtoglu Metin Chief Technology Officer 2024-12-09 Option exercise · Stock Option (Right to Buy) −10,763 82,000 D
Kurtoglu Metin Chief Technology Officer 2024-12-10 Option exercise · Stock Option (Right to Buy) −2,901 79,099 D
Open-market sales · 13,664 sh · avg $25.26 · $345,134
Loading xslF345X05/wk-form4_1733952508.xml…